Comparative Study between Intravenous and Intraperitoneal Magnesium Sulphate for Pain Management in Laparoscopic mini gastric bypass

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202111620456298

Enrollment

100

Registered

2021-11-17

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

intraperitoneal Magnesium sulfate

intravenous magnesium sulfate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: • Undergoing a scheduled laparoscopic bariatric surgery under general anaesthesia. • Age group: 18-65 years old. • BMI 35– 59.9 Kg/m2. • Both genders are eligible for study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: • Pregnant or breast-feeding women. • ASA physical status class > 3. • The need to change laparoscopic surgery to an open one. • Allergy to MgSO4. • 1st or 2nd degree Heart block. • Chronic treatment by beta-blockers. • HR < 50 bpm, • Heart failure with LVEF < 40%. • Severe chronic disease. • Alcohol or drug abuse. • Psychiatric disease. • History of chronic pain.

Design outcomes

Primary

Measure	Time frame
oNalbuphine consumption during the 48 hours following extubation.	—

Secondary

Measure	Time frame
o Postoperative pain score for 48 hours using the Visual Analogue Scale (VAS), ;o Number of episodes of PONV	—

Countries

Egypt

Contacts

Public ContactMoustafa El Sesy

Assisstant Lecturer

ms.132.184@gmail.com01123645525

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026